Envestnet Asset Management Inc Castle Biosciences Inc Transaction History

Envestnet Asset Management Inc

$263 Billion
Q1 2024

A detailed history of Envestnet Asset Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 45,927 shares of CSTL stock, worth $999,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,927

Previous 50,027 8.2%

Holding current value

$999,830

Previous $1.08 Million 5.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$18.06 - $25.3 $74,046 - $103,730	-4,100 Reduced 8.2%	45,927 $1.02 Million
Q4 2023 Feb 13, 2024	SELL	$12.19 - $22.43 $48,223 - $88,733	-3,956 Reduced 7.33%	50,027 $1.08 Million
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $245,268 - $374,920	18,469 Added 52.0%	53,983 $911,000
Q2 2023 Aug 04, 2023	BUY	$11.66 - $26.0 $126,499 - $282,074	10,849 Added 43.99%	35,514 $487,000
Q1 2023 May 11, 2023	BUY	$19.47 - $28.49 $44,255 - $64,757	2,273 Added 10.15%	24,665 $560,000

Q4 2022 Feb 07, 2023	SELL	$18.08 - $30.0 $4,592 - $7,620	-254 Reduced 1.12%	22,392 $527,000
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $1,080 - $1,647	48 Added 0.21%	22,646 $591,000
Q2 2022 Aug 03, 2022	SELL	$16.0 - $45.99 $258,848 - $744,026	-16,178 Reduced 41.72%	22,598 $496,000
Q1 2022 May 04, 2022	BUY	$33.17 - $46.98 $177,028 - $250,732	5,337 Added 15.96%	38,776 $1.74 Million
Q4 2021 Feb 04, 2022	BUY	$39.06 - $67.58 $17,225 - $29,802	441 Added 1.34%	33,439 $1.43 Million
Q3 2021 Oct 07, 2021	BUY	$60.13 - $77.6 $154,894 - $199,897	2,576 Added 8.47%	32,998 $2.19 Million
Q2 2021 Aug 04, 2021	BUY	$50.07 - $76.78 $1.13 Million - $1.73 Million	22,569 Added 287.39%	30,422 $2.23 Million
Q1 2021 May 04, 2021	BUY	$58.92 - $97.33 $462,698 - $764,332	7,853 New	7,853 $538,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Castle Biosciences Inc Transaction History